Aptar reports fourth quarter and annual results

Aptar reports fourth quarter and annual results; recaps year of pharma services acquisitions and multiple new drug delivery launches; highlights strategic steps to strengthen beauty business.q4 adjusted earnings per share $0.80.q4 earnings per share $0.73.q4 earnings per share estimate $0.78 -- refinitiv ibes data.sees q1 2020 earnings per share $0.85 to $0.93 excluding items.q4 sales $671 million versus refinitiv ibes estimate of $678.1 million.aptargroup - estimated costs associated with footprint consolidations are currently expected to be about $20 million.there will continue to be near-term challenges.aptargroup - certain beauty + home customers continuing inventory reductions considering current macroeconomic uncertainties.pharma segment is facing difficult comparisons.aptargroup - food + beverage segment's asian business may be negatively affected by coronavirus impact.q1 earnings per share view $1.04 -- refinitiv ibes data.
ATR Ratings Summary
ATR Quant Ranking